Exact Mass: 268.0978492
Exact Mass Matches: 268.0978492
Found 218 metabolites which its exact mass value is equals to given mass value 268.0978492
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-Hydroxybenzo(a)pyrene
CONFIDENCE standard compound; INTERNAL_ID 45
9-Hydroxybenzo[a]pyrene
9-Hydroxybenzo[a]pyrene, also known as benzo[Def]chrysen-9-ol or 9-hydroxybenzo(a)Pyrene, 3H-labeled, is classified as a member of the Benzopyrenes. Benzopyrenes are organic compounds containing a benzene fused to a pyrene(benzo[def]phenanthrene) ring system. 9-Hydroxybenzo[a]pyrene is considered to be practically insoluble (in water) and acidic
Benzo[a]pyrene-9,10-oxide
This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.
Benzo[a]pyrene-7,8-oxide
This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.
Benzo[a]pyrene-4,5-oxide
This compound belongs to the family of Chrysenes. These are compounds containing the polyaromatic chrysene moiety, which consists of a benzene ring fused to a phenanthrene ring system to form Benzo[a]phenanthrene. D009676 - Noxae > D002273 - Carcinogens
Musk ambrette
D009676 - Noxae > D009153 - Mutagens
Moclobemide
Moclobemide is only found in individuals that have used or taken this drug. It is a reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder.The mechanism of action of moclobemide involves the selective, reversible inhibition of MAO-A. This inhibition leads to a decrease in the metabolism and destruction of monoamines in the neurotransmitters. This results in an increase in the monoamines, relieving depressive symptoms. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AG - Monoamine oxidase a inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Cysteinyl-Phenylalanine
Cysteinyl-Phenylalanine is a dipeptide composed of cysteine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Phenylalanylcysteine
Phenylalanylcysteine is a dipeptide composed of phenylalanine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Seryltyrosine
Seryltyrosine is a dipeptide composed of serine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Tyrosyl-Serine
Tyrosyl-Serine is a dipeptide composed of tyrosine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
4-O,6-O-Benzylidene-alpha-D-glucopyranose
4,6-benzylidene-d-glucose, also known as benzylidene glucopyranose, is a member of the class of compounds known as pyranodioxins. Pyranodioxins are polycyclic compounds containing a pyranodioxin moiety, which consists of a pyran ring fused to a dioxin ring. 4,6-benzylidene-d-glucose is soluble (in water) and a very weakly acidic compound (based on its pKa). 4,6-benzylidene-d-glucose can be found in fig, which makes 4,6-benzylidene-d-glucose a potential biomarker for the consumption of this food product.
1,6,8-Trihydroxy-3,4,5-trimethyl-3,4-dihydro-1H-2-benzopyran-7-carboxylic acid
4-hydroxy-5-(1,2,3-trihydroxy-3-phenylpropyl)oxolan-2-one
6-(tert-butylsulfonyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-amine
4-(2,4,6-Trioxo-5-allylhexahydropyrimidine-5-yl)valeric acid
3-Ethoxy-5-hydroxy-4-(hydroxymethy1)-7-methoxy-6-methy1-1(3H)-isobenzofuranone|3-O-Ethyl-cyclopolsaeure|3-O-Ethylcyclopolsaeure
methyl 4-methoxy-3-(3-hydroxy-2-methyl)propionyloxy-benzoate
(3S*,4S*)-3,4-dihydro-3,4,8-trihydroxy-7-(1-hydroxyethyl)-6-methoxynaphthalen-1(2H)-one|botryosphaerone A
(3S*,4S*)-3,4-dihydro-3,4,8-trihydroxy-6-methoxy-7-(2-hydroxyethyl)naphthalen-1(2H)-one|botryosphaerone B
4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxybenzaldehyde
Di-Me ester-(R)-2-Hydroxy-2-[(4-hydroxyphenyl)methyl]butanedioic acid
moclobemide
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AG - Monoamine oxidase a inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor CONFIDENCE standard compound; INTERNAL_ID 2279 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2675
7-(1,2-dihydroxyethyl)-4,8-dihydroxy-6-methoxy-3,4-dihydro-2H-naphthalen-1-one
Ctrinin hydrate
D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Penicillium improvisum, Penicillium verrucosum
7-(1,2-dihydroxyethyl)-4,8-dihydroxy-6-methoxy-3,4-dihydro-2H-naphthalen-1-one [IIN-based: Match]
Ser-tyr
A dipeptide formed from L-serine and L-tyrosine residues.
diethyl 2,6-dimethyl-4-oxo-4h-pyran-3,5-dicarboxylate
5-(tert-butoxycarbonylamino)-2-methoxypyridine-4-carboxylic acid
2-Chloro-5-Methoxyphenylboronic acid pinacol ester
2-(2-chloro-6-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
METHYL 5-(4,4,5-TRIMETHYL-[1,3,2]DIOXABOROLAN-2-YL)THIOPHENE-2-CARBOXYLATE
1-[2-AMINO-1-(2-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
1-[2-AMINO-1-(4-CHLORO-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline
4-Cyclohexene-1, 2-dicarboxylic acid, mono[2-[(1-oxo-2-propenyl)oxy]-ethyl]ester
Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carboxylate
dimethyl 2-[(4-hydroxyphenyl)methyl]-2-methoxypropanedioate
2-Chloro-3-(hydroxymethyl)phenylboronic acid pinacol ester
6-ACETYL-2-AMINO-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER
2-Methoxycarbonylthiophene-3-boronic acid pinacol ester
Acetic acid,2-(diethoxyphosphinyl)-2-ethoxy-, ethyl ester
C10H21O6P (268.10756960000003)
tert-butyl 2-chloro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate
2-(carbamoylamino)-3-(3,4-dimethoxyphenyl)propanoic acid
2-(2-Chloro-3-methoxyphenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
TERT-BUTYL 3-CHLORO-7,8-DIHYDRO-1,6-NAPHTHYRIDINE-6(5H)-CARBOXYLATE
3-oxo-3-(3,4,5-trimethoxyphenyl)propionic acid methyl ester
3-(tert-butoxycarbonylamino)-2-Methoxyisonicotinic acid
1-(4,6-Dihydrothieno[3,4-b]thiophen-2-yl)-2-ethylhexan-1-one
3-oxo-3-(2,3,6-trimethoxyphenyl)propionic acid methyl ester
methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate
7-butyl-1,3-dimethyl-8-sulfanylidene-9H-purine-2,6-dione
methyl 2-amino-3-(1H-indol-3-yl)-2-methylpropanoate,hydrochloride
1,2-dihydro-6-hydroxy-4-methyl-2-oxo-5-[(p-tolyl)azo]nicotinonitrile
Loxoprofen sodium
C15H17NaO3 (268.10753320000003)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2-(2-OXO-2-(PIPERIDIN-1-YL)ETHYLTHIO)-6-AMINOPYRIMIDIN-4(1H)-ONE
2-(2,3-DIHYDROTHIENO[3,4-B][1,4]DIOXIN-5-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
1-(PIPERIDIN-4-YL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE HYDROCHLORIDE
3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-benzenemethanol
(2-chloro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)Methanol
TERT-BUTYL 2-FORMYL-6,7-DIHYDROTHIAZOLO[5,4-C]PYRIDINE-5(4H)-CARBOXYLATE
2-(3-Chloro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-(4-Chloro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Tolpyrramide
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent
n-[(1r,2r)-1,3-Dihydroxy-1-(4-nitrophenyl)propan-2-yl]propanamide
MUSK AMBRETTE
D009676 - Noxae > D009153 - Mutagens
4-Hydroxy-5-(1,2,3-trihydroxy-3-phenylpropyl)oxolan-2-one
5-(4-Hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolane-3-carboxylic acid
globosumone B
A benzoate ester obtained by the formal condensation of o-orsellinic acid with (4S)-1,4-dihydroxypentan-2-one. Isolated from Chaetomium globosum, it exhibits cytotoxic activity towards cancer cell lines.
N-(4-fluorophenyl)-5-methyl-1H-indole-2-carboxamide
1-(3-Hydroxy-2,4,4-trimethyl-1-oxido-5-thiophen-2-yl-2-imidazol-1-iumyl)ethanone
7-(1,2-dihydroxyethyl)-4,8-dihydroxy-6-methoxy-3,4-dihydro-2H-naphthalen-1-one
1-feruloyl-sn-glycerol
An enoate ester obtained by formal condensation of the carboxy group of trans-ferulic acid with the 1-hydroxy group of glycerol.
2,3-dihydroxypropyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
(3s,4r,5s)-4-[2,3-dihydroxy-4-(hydroxymethyl)phenyl]-3-hydroxy-5-methyloxan-2-one
n-[(1r,2r)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]propanimidic acid
4,8-dihydroxy-4-(1-hydroxyethyl)-6-methoxy-5-methyl-3h-2-benzopyran-1-one
(3s,4s)-3,4,8-trihydroxy-7-(2-hydroxyethyl)-6-methoxy-3,4-dihydro-2h-naphthalen-1-one
methyl 3-[(3-hydroxy-2-methylpropanoyl)oxy]-4-methoxybenzoate
1-o-coumaroylglycerol; (±)-(e)-form,3'-methoxy
{"Ingredient_id": "HBIN002867","Ingredient_name": "1-o-coumaroylglycerol; (±)-(e)-form,3'-methoxy","Alias": "NA","Ingredient_formula": "C13H16O6","Ingredient_Smile": "NA","Ingredient_weight": "268.26","OB_score": "NA","CAS_id": "108026-20-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9141","PubChem_id": "NA","DrugBank_id": "NA"}